Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Bekaert Finalizes Recent Share Buyback and Liquidity Actions
- Ontex Group NV Details Upcoming Q2 and H1 2025 Results
- Diversified Energy Company Takes Strategic Steps to Enhance Value
- FirstFarms A/S Secures Regional Subsidy Amid Market Adjustments
- Insightful Look at NB Private Equity Partners' Share Buy-Back
- Foresight Group Holdings Executes Strategic Share Buyback Action
- Hepsor Latvia OÜ Expands Footprint with Strategic Acquisition
- Bigbank AS Announces Strategic Merger to Enhance Efficiency
- Diversified Energy Company Announces Share Buyback Program
- Duni Group Reports Steady Growth Amid Economic Challenges
- Arasan Chip Systems Unveils Advanced eUSB2 Solutions for IoT
- Tryg A/S Reveals Financial Calendar and Future Plans
- Evergreen Group Holdings: Navigating Expansion with Confidence
- Elanders AB Reports Second Quarter Insights and Updates
- Tryg A/S Reports Strong Financial Performance in Q2 2025
- Insightful Overview of Tryg Forsikring A/S's Performance Report
- HMS Networks' Strong Growth and Future Prospects Unveiled
- Arctech's New FINAME Certification Promises Growth in LATAM
- Elanders AB Reports Financial Performance for Q2 2025
- Tryg A/S Reports Positive Growth in Q2 and H1 Financials
- Tryg Forsikring A/S 2025 Half-Year Report Highlights Unveiled
- HMS Networks Reports Strong Growth Amid Market Uncertainty
- Explore Tryg A/S's Financial Calendar and Investor Insights
- Aker Solutions ASA Achieves Strong Performance in Q2 2025
- Nvidia's Groundbreaking Achievement Beyond $4 Trillion Milestone
- Technip Energies Secures Major FLNG Contract to Boost Operations
- MARA Holdings Sees Significant Stock Surge Amid Crypto Rise
- Aker Solutions: Robust Financial Performance in Q2 2025
- Technip Energies Secures Major FLNG Project, Expanding Global Impact
- Merko Group Secures Major Wind Farm Construction Contract
- Kitron Reports Strong Q2 2025 Performance Boost from Defence
- AS Ekspress Grupp Reports Growth in Digital Subscriptions
- Kitron's Q2 Performance: Growth in Defence & Aerospace Sector
- Aker Solutions Reports Strong 2025 Financial Performance
- Zilliz’s Major Achievement: Pioneering Performance and Usability
- Zilliz Cloud Enhances AI Agents for Industry Transformation
- Innovative Partnership Sets New Standards for Smart Lighting Solutions
- Navigating the Future of Bitcoin Mining with PBK Miner
- Premium Catering's Strategic Share Consolidation and Future Plans
- Cape Horn Tequila Expands Line with Unique Añejo Offering
- Above Food Ingredients Surges 130% After Record Gains
- KT&G Expands European Presence with ESSE Brand Launch
- Embark on the Inaugural Spanglish Party Cruise Adventure
- HYCU Receives Recognition for Excellence in Workplace Culture
- Lightchain AI Secures $21.1M; Launching Grants and Staking Soon
- Brazil's Lula Vows Trade Retaliation Against U.S. Tariffs
- Dickinson Wright Files Lawsuit to Combat Illegal Short Selling
- Dickinson Wright Takes Action Against Fraudulent Sellers of DVLT
- Investing Insights: Five Key Stocks Captivating Attention
- Civista Bancshares Announces New Public Offering Pricing